Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Giovannelli

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|November 23, 2018
Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-AnalysisVincent Sobanski, Angélique Lemaire-Olivier, Jonathan Giovannelli, et al.
Autoimmunity Reviews|January 19, 2018
Altered B lymphocyte homeostasis and functions in systemic sclerosisAlexandra Forestier, Thomas Guerrier, Mathieu Jouvray, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 8, 2020
Is CCL18 a potential biomarker of type-2 asthma endotypes?Helen Fouquet, Jonathan Giovannelli, Patricia de Nadaï, et al.
Respiratory Research|October 15, 2022
Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortalitySébastien Puigrenier, Jonathan Giovannelli, Nicolas Lamblin, et al.
Plos One|January 11, 2017
Physiologic Determinants of Exercise Capacity in Pulmonary Langerhans Cell Histiocytosis: A Multidimensional AnalysisCamille Rolland-Debord, Stephanie Fry, Jonathan Giovannelli, et al.
Neurology|February 9, 2021
Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSDHelene Zephir, Julien Poupart, Romain Deschamps, et al.
Neurology|March 15, 2020
Evaluation of efficacy and tolerability of first-line therapies in NMOSDJulien Poupart, Jonathan Giovannelli, Romain Deschamps, et al.
Chest|November 23, 2019
Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in FranceEric Hachulla, David Launay, Athénaïs Boucly, et al.
Arthritis Research & Therapy|December 17, 2017
Factors associated with the 6-minute walk distance in patients with systemic sclerosisSébastien Sanges, Jonathan Giovannelli, Vincent Sobanski, et al.
Chest|December 8, 2020
Antiplatelet Drugs and Risk of Bleeding After Bedside Pleural Procedures: A National Multicenter Cohort StudyLaurence Dangers, Jonathan Giovannelli, Gilles Mangiapan, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|November 23, 2018
Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-AnalysisVincent Sobanski, Angélique Lemaire-Olivier, Jonathan Giovannelli, et al.
Autoimmunity Reviews|January 19, 2018
Altered B lymphocyte homeostasis and functions in systemic sclerosisAlexandra Forestier, Thomas Guerrier, Mathieu Jouvray, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 8, 2020
Is CCL18 a potential biomarker of type-2 asthma endotypes?Helen Fouquet, Jonathan Giovannelli, Patricia de Nadaï, et al.
Respiratory Research|October 15, 2022
Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortalitySébastien Puigrenier, Jonathan Giovannelli, Nicolas Lamblin, et al.
Plos One|January 11, 2017
Physiologic Determinants of Exercise Capacity in Pulmonary Langerhans Cell Histiocytosis: A Multidimensional AnalysisCamille Rolland-Debord, Stephanie Fry, Jonathan Giovannelli, et al.
Neurology|February 9, 2021
Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSDHelene Zephir, Julien Poupart, Romain Deschamps, et al.
Neurology|March 15, 2020
Evaluation of efficacy and tolerability of first-line therapies in NMOSDJulien Poupart, Jonathan Giovannelli, Romain Deschamps, et al.
Chest|November 23, 2019
Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in FranceEric Hachulla, David Launay, Athénaïs Boucly, et al.
Arthritis Research & Therapy|December 17, 2017
Factors associated with the 6-minute walk distance in patients with systemic sclerosisSébastien Sanges, Jonathan Giovannelli, Vincent Sobanski, et al.
Chest|December 8, 2020
Antiplatelet Drugs and Risk of Bleeding After Bedside Pleural Procedures: A National Multicenter Cohort StudyLaurence Dangers, Jonathan Giovannelli, Gilles Mangiapan, et al.
Pageof 4